Grant: Strategic Projects - Group
McMaster University
$194,755.00
Developing structurally- and functionally-tuned three-dimensional electrodes for biosensing
EF 2018-19
Résumé
Currently, there is tremendous market demand for two classes of miniaturized biosensors: (1) handheld point-of-care (POC) diagnostic s and (2) wearable health monitoring devices. The difficulty in commercializing new POC and wearable technologies is that it is extremely challenging to create ultrasensitive biosensors that do not rely on complex devices for signal or target amplification, and can detect emerging biomarkers in complex biological samples at clinically relevant concentrations.*In this proposal, we will provide a unique materials strategy for solving the limit-of-detection challenges of biosensors. The approach will be based on increasing the signal-to-background ratio of these devices. Signal enhancement will be achieved by using three-dimensional hierarchically organized electrodes that collectively increase the electrochemical current density and the probability of analyte capture through their precisely designed structure. The reduction of the background signals will be achieved by creating hybrid omniphobic electrodes featuring a unique slippery coating that captures the desired target analytes and significantly reduces the non-specific binding of background materials; andbimodal photoactive electrodes that are excited using light and are operated under low electrical bias reducing the background electrochemical processes.*The proposed project will combine these unique materials approaches for the first time and is expected to: (1) result in record values in terms of limit-of-detection enabling the development of several new classes of biosensors including wearable sensors; (2) generate new knowledge in the correlation between materials structure and function in the biosensing context; (3) result in a rich multidisciplinary training environment with skills that are transferrable to several sectors; (4) provide our industry partner, a global leader in POC diagnostics in Canada and globally, a competitive advantage resulting in significant economic and health benefits to Canadians, including new direct and indirect jobs, availability of high quality diagnostic testing in remote areas, and more efficient use of healthcare funds.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
506320-2017
Name nom
Soleymani, Leyla
Department département
Engineering Physics
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2017
Award amount
194755
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1586
Committee name en
Strategic Projects - Advanced Manufacturing
Committee name fr
Projets stratégiques - Fabrication de pointe
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
2001
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials structure, properties and testing
Research subject fr
Structure, propriétés et essais des matériaux
Partie
2
Nb partie
2
Application title
Developing structurally- and functionally-tuned three-dimensional electrodes for biosensing
Keyword
NSERC
Application summary
Currently, there is tremendous market demand for two classes of miniaturized biosensors: (1) handheld point-of-care (POC) diagnostic s and (2) wearable health monitoring devices. The difficulty in commercializing new POC and wearable technologies is that it is extremely challenging to create ultrasensitive biosensors that do not rely on complex devices for signal or target amplification, and can detect emerging biomarkers in complex biological samples at clinically relevant concentrations.*In this proposal, we will provide a unique materials strategy for solving the limit-of-detection challenges of biosensors. The approach will be based on increasing the signal-to-background ratio of these devices. Signal enhancement will be achieved by using three-dimensional hierarchically organized electrodes that collectively increase the electrochemical current density and the probability of analyte capture through their precisely designed structure. The reduction of the background signals will be achieved by creating hybrid omniphobic electrodes featuring a unique slippery coating that captures the desired target analytes and significantly reduces the non-specific binding of background materials; andbimodal photoactive electrodes that are excited using light and are operated under low electrical bias reducing the background electrochemical processes.*The proposed project will combine these unique materials approaches for the first time and is expected to: (1) result in record values in terms of limit-of-detection enabling the development of several new classes of biosensors including wearable sensors; (2) generate new knowledge in the correlation between materials structure and function in the biosensing context; (3) result in a rich multidisciplinary training environment with skills that are transferrable to several sectors; (4) provide our industry partner, a global leader in POC diagnostics in Canada and globally, a competitive advantage resulting in significant economic and health benefits to Canadians, including new direct and indirect jobs, availability of high quality diagnostic testing in remote areas, and more efficient use of healthcare funds.